Incidence of putative HIV superinfection and sexual practices among HIV-infected men who have sex with men

Sexual Health

Volumn 5, Issue 1, 2008, Pages 61-67

  Sidat, Mohsin M ^a   Mijch, Anne M ^b   Lewin, Sharon R ^b,c   Hoy, Jennifer F ^b,c   Hocking, Jane ^a   Fairley, Christopher K ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

Author keywords

HIV superinfection; Men who have sex with men; Unsafe sexual practices

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; RETROSPECTIVE STUDY; RNA ANALYSIS; SEXUAL BEHAVIOR; SUPERINFECTION;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CONFIDENCE INTERVALS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; SEXUAL PARTNERS; SUPERINFECTION;

EID: 39749151188     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH07041     Document Type: Article

References (48)

1. UNAIDS. AIDS epidemic update: December 2005; Geneva, Switzerland: UNAIDS/WHO; 2005.
2. Volk JE, Prestage G, Jin F, Kaldor J, Ellard J, Kippax S, et al. Risk factors for HIV seroconversion in homosexual men in Australia. Sex Health 2006; 3: 45-51. doi: 10.1071/SH05020
3. Blackard JT, Mayer KH. HIV superinfection in the era of increased sexual risk-taking. Sex Transm Dis 2004; 31: 201-4. doi: 10.1097/01.OLQ. 0000118082.45312.1F
4. Smith DM, Richman DD, Little SJ. HIV superinfection. J Infect Dis 2005; 192: 438-44. doi: 10.1086/431682
5. Steain MC, Wang B, Dwyer DE, Saksena NK. HIV-1 co-infection, superinfection and recombination. Sex Health 2004; 1: 239-50. doi: 10.1071/SH04024
6. Allen TM, Altfeld M. HIV-1 superinfection. J Allergy Clin Immunol 2003; 112: 829-35. doi: 10.1016/j.jaci.2003.08.037
7. Chan DJ. HIV-1 superinfection: evidence and impact. Curr HIV Res 2004; 2: 271-4. doi: 10.2174/1570162043351219
8. Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Grobler J, Li F, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet 2004; 363: 619-22. doi: 10.1016/S0140-6736(04)15596-7
9. Grobler J, Gray CM, Rademeyer C, Seoighe C, Ramjee G, Karim SA, et al. Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 2004; 190: 1355-9. doi: 10.1086/423940
10. Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, et al. Recombination following superinfection by HIV-1. AIDS 2004; 18: 153-9. doi: 10.1097/00002030-200401230-00003
11. Chohan B, Lavreys L, Rainwater SMJ, Overbaugh J. Evidence of frequent reinfection with human immunodeficiency virus type 1 of a different subtype. J Virol 2005; 79: 10701-8. doi: 10.1128/JVI.79.16.10701-10708.2005
12. Manigart O, Courgnaud V, Sanou O, Valéa D, Nagot N, Meda N, et al. HIV-1 superinfection in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure. AIDS 2004; 18: 1645-51. doi: 10.1097/01.aids.0000131333.30548.db
13. Tsui R, Herring BL, Barbour JD, Grant RM, Bacchetti P, Kral A, et al. Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. J Virol 2004; 78: 94-103. doi: 10.1128/JVI.78.1.94-103.2004
14. Yerly S, Jost S, Monnat M, Telenti A, Cavassini M, Chave JP, et al. HIV-1 co/superinfection in intravenous drug users. AIDS 2004; 18: 1413-21. doi: 10.1097/01.aids.0000131330.28762.0c
15. Smith DM, Wong JK, Daar ES, Richman DD, Little SJ. Incidence of HIV superinfection following primary infection. JAMA 2004; 292: 1177-8. doi: 10.1001/jama.292.10.1177
16. Gonzales MJ, Delwart EL, Rhee S, Tsui R, Zolopa AR, Taylor J, et al. Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation. J Infect Dis 2003; 188: 397-405. doi: 10.1086/376534
17. Smith D, Wong J, Hightower G, Kolesch K, Ignacio C, Daar E, et al. Incidence of HIV superinfection following primary infection. In: 11th Conference on Retroviruses and Opportunistic Infections; February 2004; San Francisco, CA, USA. [Abstract 21]
18. Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TR, Brown AJ, et al. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS 2003; 17: F11-6. doi: 10.1097/00002030-200305020-00001
19. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, et al. HIV drug resistance acquired through superinfection. AIDS 2005; 19: 1251-6.
20. Brenner B, Routy JP, Quan Y, Moisi D, Oliveira M, Turner D, et al. Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS 2004; 18: 1653-60. doi: 10.1097/01.aids.0000131377. 28694.04
21. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, et al. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol 2005; 79: 860-8. doi: 10.1128/JVI.79.2.860-868. 2005
22. Chakraborty B, Kiser P, Rangel HR, Weber J, Mirza M, Marotta ML, et al. Can HIV-1 superinfection compromise antiretroviral therapy? AIDS 2004; 18: 132-4.
23. Colfax GN, Guzman R, Wheeler S, Mansergh G, Marks G, Rader M, et al. Beliefs about HIV reinfection (superinfection) and sexual behavior among a diverse sample of HIV-positive men who have sex with men. J Acquir Immune Defic Syndr 2004; 36: 990-2. doi: 10.1097/00126334-200408010-00017
24. SPSS. SPSS for Windows (version 12.0.1). Chicago: SPSS; 2003.
25. Kippax S, Noble J, Prestage G, Crawford JM, Campbell D, Baxter D, et al. Sexual negotiation in the AIDS era: negotiated safety revisited. AIDS 1997; 11: 191-7. doi: 10.1097/00002030-199702000-00009
26. Jin F, Prestage G, Mao L, Kippax S, Pell C, Donovan B, et al. Anal sexually transmissible infections as risk factors for HIV seroconversion: data from HIM cohort. In: 18th Annual Australasian Society for HIV Medicine Conference; October 2006; Melbourne, Australia.
27. Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum CL, Seage GR 3rd, Judson FN, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 2005; 39: 82-9. doi: 10.1097/01.qai.0000134740.41585.f4
28. Sutmoller F, Penna TL, de Souza C, Lambert J, Oswaldo Cruz Foundation STD/HIV Prevention Group. Human immunodeficiency virus incidence and risk behavior in the 'Projecto Rio': results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994-98. Int J Infect Dis 2002; 6: 259-65. doi: 10.1016/S1201-9712(02)90158-X
29. Centers for Disease Control and Prevention. HIV incidence among young men who have sex with men - seven US cities, 1994-2000. Centers for Disease Control and Prevention: Atlanta; 2001. pp. 440-4.
30. Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity. AIDS 2004; 18: 1513-20. doi: 10.1097/01.aids.0000131361.75328.47
31. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002; 420: 434-9. doi: 10.1038/nature01200
32. Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis 2002; 34: 1108-14. doi: 10.1086/339547
33. van Kesteren N, Hospers HJ, Kok G, van Empelen P. Sexuality and sexual risk behavior in HIV-positive men who have sex with men. Qual Health Res 2005; 15: 145-68. doi: 10.1177/1049732304270817
34. Adam BD, Husbands W, Murray J, Maxwell J. Risk construction in the reinfection discourses of HIV-positive men. Health Risk Soc 2005; 7: 63-71. doi: 10.1080/13698570500042272
35. Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, et al. A patient with HIV-1 superinfection. N Engl J Med 2002; 347: 731-6. doi: 10.1056/NEJMoa020263
36. van der Kuyl A, Kozaczynska K, van den Burg R, Zorgdrager F, Back N, Jurriaans S, et al. Triple HIV-1 infection. N Engl J Med 2005; 352: 2557-9. doi: 10.1056/NEJM200506163522420
37. McCutchan FE, Hoelscher M, Tovanabutra S, Piyasirisilp S, Sanders-Buell E, Ramos G, et al. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection. J Virol 2005; 79: 11 693-704. doi: 10.1128/JVI.79.18.11693-11704.2005
38. Deeks SG, Kitchen CMR, Liu L, Guo H, Gascon R, Narváez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104: 942-7. doi: 10.1182/blood-2003-09-3333
39. Lewin S, Ribeiro RM, Kaufmann GR, Smith D, Zaunders J, Law M, et al. Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection. J Immunol 2002; 169: 4657-66.
40. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18: 2075-9. doi: 10.1097/00002030-200410210-00012
41. Vassend O, Eskild A. Psychological distress, coping, and disease progression in HIV-positive homosexual men. J Health Psychol 1998; 3: 243-57.
42. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993; 270: 2568-73. doi: 10.1001/jama.270.21.2568
43. Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996; 334: 1222-30. doi: 10.1056/NEJM199605093341903
44. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185: 621-8. doi: 10.1084/jem.185.4.621
45. Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989; 63: 2118-25.
46. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992; 66: 1354-60.
47. Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20: 111-26. doi: 10.1089/088922204322749567
48. 6 L clinical disease. AIDS 1994; 8: 1577-84. doi: 10.1097/00002030-199411000-00009